Alpha-fetoprotein (AFP) is primarily synthesized in the liver during fetal development, with levels peaking at birth and subsequently declining rapidly. Beyond pregnancy and childbirth, a notable rise occurs due to liver damage and certain tumors, making it a useful tumor marker. This test serves as a diagnostic indicator for liver and cancer-related conditions.